Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release

NCT05398640 is registered in ClinicalTrials.gov with Iovance Biotherapeutics, Inc. as lead sponsor.

NCT NCT05398640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05398640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release
Lead sponsor
Iovance Biotherapeutics, Inc.
Phase
Expanded access
Overall status
Available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma, unresectable melanoma